View Future GrowthNextleaf Solutions 과거 순이익 실적과거 기준 점검 0/6Nextleaf Solutions은 연평균 55.1%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 연평균 8.8%의 비율로 증가했습니다. 매출은 연평균 33.9%의 비율로 증가했습니다.핵심 정보55.10%순이익 성장률59.05%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률7.33%매출 성장률33.94%자기자본이익률-8.93%순이익률-3.81%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2022). Revenue: CA$2.17m (up 90% from 2Q 2022). Net loss: CA$25.2k (loss narrowed 96% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updates공시 • Mar 03Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026.공시 • Jan 31Nextleaf Solutions Ltd. Auditor Raises 'Going Concern' DoubtNextleaf Solutions Ltd. filed its Annual on Jan 29, 2025 for the period ending Sep 30, 2024. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.공시 • Dec 26Nextleaf Solutions Ltd. Announces 14 New Product Listings Nationwide Across 4 CategoriesNextleaf Solutions Ltd. announced 14 new product listings nationally across 4 categories, and the date for their Annual General Meeting, which will be held on January 30th 2025, in Vancouver, BC. New Products and Innovation. Nextleaf announced 14 new listings under their brand Glacial Gold, across 4 categories including vapes, softgels, oils, and infused prerolls. These listings will launch between January and April 2025 nationwide. The product pipeline focuses on smokeless ingestible extracts such as softgels and oils, ready-to-consume convenience formats like All-in-One liquid diamond vapes, infused prerolls, and minor cannabinoid formulations (notably CBG and CBN) across multiple categories. These products solidify Nextleaf's market leadership in these emerging segments. Regional Product Listings. Ontario (4 new listings): Glacial Gold RSO Full Spectrum 5:5 Softgels 100-pack. Glacial Gold Atmosphere Tart Cherry CBN:THC Vape Cartridge 1.2g. Glacial Gold Atmosphere CBN:THC 15mg:15mg Oil Drops 35ml. Alberta (4 new listings: Glacial Gold Liquid Diamonds Pure Diamonds All-in-One Vape 0.95g. Glacial Gold HIGH THC Banger Cherry Bomb All-in-One Vapes 1g. Glacial Gold Atmosp Here CBN:THC 15 mg:15mg Oil Drops 35g. Glacial Gold Atmospwhere CBN:THC 15g:15mg Oil Drops 35 ml. British Columbia (6 new listings): Glacial Gold Atmosphere CBG:THC Tart Cherry Vape Cartridge 1. 2g. Glacial Gold atmospherehere CBN:THC Melon Baller Vape Cartridge1.2g. glacial Gold Atmosphere CBN;THC Oil Drops 35ml. Glacial Gold Liquid Diamonds All-in- One Vape 0.95g; Glacial Gold HIGH THC Bangers Cherry Bomb Infused Preroll 3 x 0.5g (unflavoured) Glacial Gold High THC Banger Cherry Bomb Infused Preroll3 x 0.5g.공시 • Dec 02Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025.공시 • Sep 26Nextleaf Solutions Ltd. Appoints Emma Andrews as Permanent Chief Executive OfficerNextleaf Solutions Ltd. announced the permanent appointment of Emma Andrews as the Chief Executive Officer of the Company. Andrews has acted as the Company's Interim CEO since September 8, 2023, and has been with the company for 6 years, previously as the Director of Marketing. Emma Andrews helped guide the company's commercial strategy and led the entry into consumer-packaged goods, including the company's re-launch of prohibition-era brand Glacial Gold into the regulated landscape. Andrews brings a wealth of expertise in consumer-packaged goods, having spent over 10 years leading teams, launching brands, and developing products for the natural health industry. She is a Registered Nutritionist (RHN) and certified in New Product Development (NPDP). Her most notable tenure was with plant-based nutrition company Vega, leading to a CAD 750 million acquisition by White Wave Foods in 2015.New Risk • Sep 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€8.21m market cap, or US$9.11m). Minor Risk Shareholders have been diluted in the past year (3.3% increase in shares outstanding).Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.공시 • Oct 21Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023.공시 • Sep 12+ 1 more updateNextleaf Solutions Ltd. Announces an Executive ChangeThe board of directors of Nextleaf Solutions Ltd. has announced the departure of Paul Pedersen from his role as Chief Executive Officer, effective September 08, 2023. Pedersen had been Nextleaf's CEO since inception and remains on the Board of Directors. The company announced the appointment of Emma Andrews, BA, RHN, NPDP to the role of Interim Chief Executive Officer. Andrews has worked closely with Nextleaf leadership and executive team since the company's origin, most recently as the Director of Marketing she oversaw the company's entry into branded consumer products, and was integral in creating the company's mission, vision, values, and corporate identity. Andrews has held senior management and public company executive officer roles across every vertical in the cannabis industry including cultivation/harvesting, processing, retail, ancillary, and consumer products. This is in addition to over a decade working in the Natural Products Industry to help scale emerging brands into category leaders.Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2022). Revenue: CA$2.17m (up 90% from 2Q 2022). Net loss: CA$25.2k (loss narrowed 96% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 04First quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2022)First quarter 2023 results: CA$0.004 loss per share (improved from CA$0.007 loss in 1Q 2022). Revenue: CA$1.19m (up 3.3% from 1Q 2022). Net loss: CA$559.0k (loss narrowed 39% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 01Full year 2022 earnings released: CA$0.025 loss per share (vs CA$0.044 loss in FY 2021)Full year 2022 results: CA$0.025 loss per share (improved from CA$0.044 loss in FY 2021). Revenue: CA$4.41m (up 31% from FY 2021). Net loss: CA$3.49m (loss narrowed 35% from FY 2021). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Oct 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 31Third quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.011 loss in 3Q 2021)Third quarter 2022 results: CA$0.007 loss per share (up from CA$0.011 loss in 3Q 2021). Revenue: CA$1.20m (up 83% from 3Q 2021). Net loss: CA$1.05m (loss narrowed 22% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 35% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 01Second quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.01 loss in 2Q 2021)Second quarter 2022 results: CA$0.004 loss per share (up from CA$0.01 loss in 2Q 2021). Revenue: CA$1.15m (up CA$1.01m from 2Q 2021). Net loss: CA$606.9k (loss narrowed 49% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.Reported Earnings • Jun 02Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.012 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$130.5k (up 24% from 2Q 2020). Net loss: CA$1.19m (loss narrowed 12% from 2Q 2020).Is New 90 Day High Low • Jan 15New 90-day high: €0.24The company is up 129% from its price of €0.10 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 19% over the same period.매출 및 비용 세부 내역Nextleaf Solutions가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:L0MA 매출, 비용 및 순이익 (CAD Millions)날짜매출순이익일반관리비연구개발비31 Dec 251103030 Sep 251103030 Jun 251213031 Mar 251203031 Dec 2412-14030 Sep 2412-14030 Jun 2412-14031 Mar 241103031 Dec 231012030 Sep 23802030 Jun 236-12031 Mar 235-32031 Dec 224-33030 Sep 224-33030 Jun 225-53031 Mar 224-53031 Dec 213-53030 Sep 213-53030 Jun 212-63031 Mar 212-53031 Dec 202-64030 Sep 201-64030 Jun 200-65031 Mar 200-65031 Dec 190-107030 Sep 190-96030 Jun 190-85031 Mar 190-64031 Dec 180-32030 Sep 181-22030 Jun 180-21030 Sep 170-100양질의 수익: L0MA 은(는) 현재 수익성이 없습니다.이익 마진 증가: L0MA는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: L0MA는 수익성이 없지만 지난 5년 동안 연평균 55.1%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 L0MA의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: L0MA은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(16.1%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: L0MA는 현재 수익성이 없으므로 자본 수익률이 음수(-8.93%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 08:01종가2026/05/21 00:00수익2025/12/31연간 수익2025/09/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Nextleaf Solutions Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2022). Revenue: CA$2.17m (up 90% from 2Q 2022). Net loss: CA$25.2k (loss narrowed 96% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
공시 • Mar 03Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026Nextleaf Solutions Ltd., Annual General Meeting, Apr 30, 2026.
공시 • Jan 31Nextleaf Solutions Ltd. Auditor Raises 'Going Concern' DoubtNextleaf Solutions Ltd. filed its Annual on Jan 29, 2025 for the period ending Sep 30, 2024. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
공시 • Dec 26Nextleaf Solutions Ltd. Announces 14 New Product Listings Nationwide Across 4 CategoriesNextleaf Solutions Ltd. announced 14 new product listings nationally across 4 categories, and the date for their Annual General Meeting, which will be held on January 30th 2025, in Vancouver, BC. New Products and Innovation. Nextleaf announced 14 new listings under their brand Glacial Gold, across 4 categories including vapes, softgels, oils, and infused prerolls. These listings will launch between January and April 2025 nationwide. The product pipeline focuses on smokeless ingestible extracts such as softgels and oils, ready-to-consume convenience formats like All-in-One liquid diamond vapes, infused prerolls, and minor cannabinoid formulations (notably CBG and CBN) across multiple categories. These products solidify Nextleaf's market leadership in these emerging segments. Regional Product Listings. Ontario (4 new listings): Glacial Gold RSO Full Spectrum 5:5 Softgels 100-pack. Glacial Gold Atmosphere Tart Cherry CBN:THC Vape Cartridge 1.2g. Glacial Gold Atmosphere CBN:THC 15mg:15mg Oil Drops 35ml. Alberta (4 new listings: Glacial Gold Liquid Diamonds Pure Diamonds All-in-One Vape 0.95g. Glacial Gold HIGH THC Banger Cherry Bomb All-in-One Vapes 1g. Glacial Gold Atmosp Here CBN:THC 15 mg:15mg Oil Drops 35g. Glacial Gold Atmospwhere CBN:THC 15g:15mg Oil Drops 35 ml. British Columbia (6 new listings): Glacial Gold Atmosphere CBG:THC Tart Cherry Vape Cartridge 1. 2g. Glacial Gold atmospherehere CBN:THC Melon Baller Vape Cartridge1.2g. glacial Gold Atmosphere CBN;THC Oil Drops 35ml. Glacial Gold Liquid Diamonds All-in- One Vape 0.95g; Glacial Gold HIGH THC Bangers Cherry Bomb Infused Preroll 3 x 0.5g (unflavoured) Glacial Gold High THC Banger Cherry Bomb Infused Preroll3 x 0.5g.
공시 • Dec 02Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025Nextleaf Solutions Ltd., Annual General Meeting, Jan 30, 2025.
공시 • Sep 26Nextleaf Solutions Ltd. Appoints Emma Andrews as Permanent Chief Executive OfficerNextleaf Solutions Ltd. announced the permanent appointment of Emma Andrews as the Chief Executive Officer of the Company. Andrews has acted as the Company's Interim CEO since September 8, 2023, and has been with the company for 6 years, previously as the Director of Marketing. Emma Andrews helped guide the company's commercial strategy and led the entry into consumer-packaged goods, including the company's re-launch of prohibition-era brand Glacial Gold into the regulated landscape. Andrews brings a wealth of expertise in consumer-packaged goods, having spent over 10 years leading teams, launching brands, and developing products for the natural health industry. She is a Registered Nutritionist (RHN) and certified in New Product Development (NPDP). Her most notable tenure was with plant-based nutrition company Vega, leading to a CAD 750 million acquisition by White Wave Foods in 2015.
New Risk • Sep 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Market cap is less than US$10m (€8.21m market cap, or US$9.11m). Minor Risk Shareholders have been diluted in the past year (3.3% increase in shares outstanding).
Reported Earnings • Sep 01Third quarter 2024 earnings released: CA$0.002 loss per share (vs CA$0.003 profit in 3Q 2023)Third quarter 2024 results: CA$0.002 loss per share (down from CA$0.003 profit in 3Q 2023). Revenue: CA$3.05m (up 37% from 3Q 2023). Net loss: CA$317.3k (down 176% from profit in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
Reported Earnings • May 30Second quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0 in 2Q 2023)Second quarter 2024 results: CA$0.006 loss per share (further deteriorated from CA$0 in 2Q 2023). Revenue: CA$3.42m (up 57% from 2Q 2023). Net loss: CA$1.01m (loss widened CA$986.7k from 2Q 2023). Over the last 3 years on average, earnings per share has increased by 76% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 03First quarter 2024 earnings released: EPS: CA$0.001 (vs CA$0.004 loss in 1Q 2023)First quarter 2024 results: EPS: CA$0.001 (up from CA$0.004 loss in 1Q 2023). Revenue: CA$3.20m (up 170% from 1Q 2023). Net income: CA$132.8k (up CA$691.8k from 1Q 2023). Profit margin: 4.1% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
Reported Earnings • Jan 31Full year 2023 earnings released: EPS: CA$0.001 (vs CA$0.025 loss in FY 2022)Full year 2023 results: EPS: CA$0.001 (up from CA$0.025 loss in FY 2022). Revenue: CA$8.18m (up 86% from FY 2022). Net income: CA$223.3k (up CA$3.71m from FY 2022). Profit margin: 2.7% (up from net loss in FY 2022). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
공시 • Oct 21Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023Nextleaf Solutions Ltd., Annual General Meeting, Dec 19, 2023.
공시 • Sep 12+ 1 more updateNextleaf Solutions Ltd. Announces an Executive ChangeThe board of directors of Nextleaf Solutions Ltd. has announced the departure of Paul Pedersen from his role as Chief Executive Officer, effective September 08, 2023. Pedersen had been Nextleaf's CEO since inception and remains on the Board of Directors. The company announced the appointment of Emma Andrews, BA, RHN, NPDP to the role of Interim Chief Executive Officer. Andrews has worked closely with Nextleaf leadership and executive team since the company's origin, most recently as the Director of Marketing she oversaw the company's entry into branded consumer products, and was integral in creating the company's mission, vision, values, and corporate identity. Andrews has held senior management and public company executive officer roles across every vertical in the cannabis industry including cultivation/harvesting, processing, retail, ancillary, and consumer products. This is in addition to over a decade working in the Natural Products Industry to help scale emerging brands into category leaders.
Reported Earnings • Sep 03Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.007 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.003 (up from CA$0.007 loss in 3Q 2022). Revenue: CA$2.22m (up 85% from 3Q 2022). Net income: CA$419.9k (up CA$1.47m from 3Q 2022). Profit margin: 19% (up from net loss in 3Q 2022). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 47% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02Second quarter 2023 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2022)Second quarter 2023 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2022). Revenue: CA$2.17m (up 90% from 2Q 2022). Net loss: CA$25.2k (loss narrowed 96% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 04First quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2022)First quarter 2023 results: CA$0.004 loss per share (improved from CA$0.007 loss in 1Q 2022). Revenue: CA$1.19m (up 3.3% from 1Q 2022). Net loss: CA$559.0k (loss narrowed 39% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 01Full year 2022 earnings released: CA$0.025 loss per share (vs CA$0.044 loss in FY 2021)Full year 2022 results: CA$0.025 loss per share (improved from CA$0.044 loss in FY 2021). Revenue: CA$4.41m (up 31% from FY 2021). Net loss: CA$3.49m (loss narrowed 35% from FY 2021). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 51% per year, which means it is significantly lagging earnings.
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Oct 13Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Sherry Boodram was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 31Third quarter 2022 earnings released: CA$0.007 loss per share (vs CA$0.011 loss in 3Q 2021)Third quarter 2022 results: CA$0.007 loss per share (up from CA$0.011 loss in 3Q 2021). Revenue: CA$1.20m (up 83% from 3Q 2021). Net loss: CA$1.05m (loss narrowed 22% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has fallen by 35% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 01Second quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.01 loss in 2Q 2021)Second quarter 2022 results: CA$0.004 loss per share (up from CA$0.01 loss in 2Q 2021). Revenue: CA$1.15m (up CA$1.01m from 2Q 2021). Net loss: CA$606.9k (loss narrowed 49% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
Reported Earnings • Jun 02Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.012 loss in 2Q 2020)The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: CA$130.5k (up 24% from 2Q 2020). Net loss: CA$1.19m (loss narrowed 12% from 2Q 2020).
Is New 90 Day High Low • Jan 15New 90-day high: €0.24The company is up 129% from its price of €0.10 on 16 October 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 19% over the same period.